Phytotherapeutic medicines in the treatment of acute respiratory infections in children

Authors

  • N. P. Gliadelova Shupyk National Medical Academy for Postgraduate Education, Kyiv, Ukraine, Ukraine
  • V. G. Kozachuk Shupyk National Medical Academy for Postgraduate Education, Kyiv, Ukraine, Ukraine https://orcid.org/0000-0003-1981-7347

Keywords:

acute respiratory viral infections, children, herbal medicine, Malipin

Abstract

Acute respiratory viral infections (ARVIs) are not only the leading cause of acute infectious diseases worldwide, but also the major cause of death among children. A special place among the symptoms of acute respiratory viral infections belongs to fever. A brief review of antipyretic drugs that are used in the treatment of acute respiratory viral infections in children is made. Antipyretic drugs do not affect the cause of the fever, do not reduce its total duration, they inhibit anti-infection protection, so their choice is based not on the strength of the effect, but on their safety. Herbal medicines are characterized by a mild therapeutic effect, a complex effect on various parts of the pathological process, low toxicity, and the possibility of prolonged use. For the relief of symptoms of acute respiratory viral infections, linden flowers have long been used. The plant is unique due to its complex effect on all symptoms of acute respiratory viral infections — fever, sore throat, cough, nasal congestion. Malipin is a natural herbal preparation containing linden extract, which has no analogues in the pharmaceutical market. A clinical study of the efficacy and safety of the phytopreparation Malipin is presented, the results of which prove feasibility of its inclusion in the treatment plan for acute respiratory viral infections in children.

References

Brenda L. Tesini. (2018). Overview of Viral Respiratory Infections. https://www.msdmanuals.com/

Delyagin VM. (2013). Likhoradka. Mnogoobrazie prichin i slozhnost` resheniya. Ukrainskyi medychnyi chasopys. 1(93): 93–96.

Hryp ta HRVI v Ukraini. Informatsiinyi biuleten za 4 tyzhden (20–26.01.2020. https://phc.org.ua/sites/default/files/users/user90/flu_operinfo_2020_04.pdf

MOZ Ukrainy. (2014). Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry hrypi ta hostrykh respiratornykh infektsiiakh. Nakaz MOZ Ukrainy vid 16.07.2014 No.499. http://www.dec.gov.ua/

Nagornaya NV, Koval` AP, Dudchak AP, Bordyugova EV. (2014). Razmy`shleniya pediatra nad patogeneticheskoj obosnovannost`yu fitoterapii u detej s ORVI. Zdorov`e rebenka. 3(54): 115–118.

Randomizirovannoe, otkry`toe issledovanie po izucheniyu e`ffektivnosti i perenosimosti lekarstvennogo sredstva MALIPIN (LIPOMAL), sirop (OOO Aflofarm Farmacziya Pol`ska, Pol`sha) v kompleksnom lechenii paczientov v vozraste ot 1 do 6 let s ostry`mi respiratorny`mi virusny`mi infekcziyami v sravnenii s gruppoj paczientov, poluchayushhikh tol`ko bazisnuyu terapiyu. Klinicheskij otchet F-F-AP/MAL/01 Malipin (2014)

Sokolov SYa. (2000). Fitoterapiya i fitofarmakologiya. Rukovodstvo dlya vrachej. Moskva: MIA: 976.

The problem of antibiotic resistance and the possibility of phytotherapy in the treatment of respiratory infections in children. (2014). Sovremennaya Pediatriya.1(57): 23–28.

Thompson WW, Shay DK, Weintraub E et al. (2004). Influenza-associated hospitalizations in the United States. JAMA. 292: 1333–40. https://doi.org/10.1001/jama.292.11.1333; PMid:15367555

Thompson WW, Shay DK, Weintraub E et al. (2003). Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 289: 179–86. https://doi.org/10.1001/jama.289.2.179; PMid:12517228

Zakliuchna informatsiia shchodo pidsumkiv epidemichnoho sezonu z hrypu ta hostrykh respiratornykh infektsii 2018–2019. https://phc.org.ua

http:// www.who.int/vaccine_ research/diseases/ari /en/index1.html

Issue

Section

Practical doctor school